2Patei A,Jhiang S,Dogra S,et al.Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.Pediat Res,2002,529:737-744. 被引量：1
1Woodrum DT, Gauger PG. Role of ^131Ⅰ treatment of well differentiated thyroid cancer[ J ]. J Surg Oncol, 2005,89 : 114 - 121. 被引量：1
2Balan KK, Raouf AH, Critchley M. Outcomes of 249 patients attending a nuclear medicine department with well differentiated thyroid cancer[ J ]. Br J Radiol, 1994,67:283 - 291. 被引量：1
5Ross DS. Long-term management of differentiated thyroid cancer[J]. Endocrinol Metab Clin North Am, 1990,19:719 - 740. 被引量：1
6Hindie E, Zanotti- Fregonara P, Duront F,et al. Should 'lowrisk' thyroid cancer patients with residual thyroglobulin be retreated with iodine 1317 [J]. Clin Endocrinol, 2007,66 . 329 - 334. 被引量：1
7Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2006,16. 109 - 142. 被引量：1
8Pacini F, Schlumberger M, Dralle H, etal. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium[J]. Eur J Endocrinol, 2006, 154: 787-803. 被引量：1
9Pace L, Klain M, Albanese C, et al. Short - term outcome of differentiated thyroid cancer patients receiving a second iodine - 131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment[J]. Eur J Nuclear Med Molecul Imag, 2006, 33:179-183. 被引量：1
10Kloos RT, Mazzaferri EL. A single recombinant human thyrotrophinstimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later[J]. J Clin Endocrinol Metabol, 2005, 0. 5047- 5057. 被引量：1
4Patel A, Jhiang S, Dogra S, et al. Differentiated thyroid carcinoma that expreaa sodium-iodide symporter have a lower risk of recurrence for children and adolescents [J]. Pediat Res,2002,52(5) :737-744. 被引量：1
5Norden MM, Larsson F, Tedelind S, et al. Do wn regulation of the Sodium/Iodide Symporter Ex- plains 131I-Induced Thyroid Stunning [J].Cancer Res, 2007, 67(15):712-717. 被引量：1
6Verburg FA, Verkooijen RB, Stokkel MP, et al. The success of 131I ablation in thyroid cancer pa- tients is significantly reduced after a diagnostic ac- tivity of 40 MBq 131I [J]. Nuklearmedizin, 2009, 48(4):138-142. 被引量：1
7Sisson JC, Avram AM, Lawson SA, et al. The So Called Stunning of Thyroid Tissue[J]. J Nucl Med, 2006, 47(9):1 406-1 412. 被引量：1
8Lundh C, Lindencrona U, Postgrd P, et al. Radi- ation-induced thyroid stunning: differential effects of 123I, 131I, 99mTc, and 211I At on iodide transport and NIS mRNA expression in cultured thyroid cells[J]. J NuclMed, 2009, 50(7):1 161-1 167. 被引量：1
9Caballero Calabuig E, Cano Terol C, 5opena Mo- nforte R, etal. Influence of the thyroid remnant in the elevation of the serum thyroglobulin after thy- roideetomy in differentiated thyroid carcinoma. Importance of the diagnostic iodine total-body scannlng[J]. Eur J Nucl Med Mol Imaging, 2008, 35(8):1 449-1 456. 被引量：1
10Medvedec M. Thyroid stunning in vivo and in vi- tro [J]. Nucl Med Commun, 2005, 26 ( 8): 731-735. 被引量：1
